Tag Archives: Acerta Pharma

AstraZeneca, Acerta Pharma, MedImmune to present at the 2018 American Society of Hematology (ASH) Annual Meeting & Exposition in San Diego

Posted on 29, November 2018 by

27 scientific presentations, including long-term data from Calquence in mantle cell lymphoma and updated early-phase trial results in chronic lymphocytic leukaemia New data on six medicines and potential new medicines across a variety of blood cancers demonstrate breadth of haematology portfolio … Read the full press release →

Posted in Healthcare, Pharma & Biotech, United Kingdom

Tagged , , , , , , , ,

University of Southampton: new experimental drug in certain patients with diffuse large B-cell lymphoma

Posted on 14, August 2017 by

SOUTHAMPTON, 14-Aug-2017 — /EuropaWire/ — Patients with a common type of fast-growing cancer are being given fresh hope in a new clinical trial. Scientists at the University of Southampton are, for the first time, to trial a new experimental drug, in … Read the full press release →

Posted in Education, Healthcare, Pharma & Biotech, United Kingdom

Tagged , , , , ,

Acerta Pharma: US FDA accepted and granted Priority Review for the New Drug Application (NDA) for acalabrutinib inhibitor

Posted on 7, August 2017 by

CAMBRIDGE, 07-Aug-2017 — /EuropaWire/ — AstraZeneca and its haematology research and development centre of excellence, Acerta Pharma, today announced that the US Food and Drug Administration (FDA) has accepted and granted Priority Review for the New Drug Application (NDA) for acalabrutinib, … Read the full press release →

Posted in Healthcare, Pharma & Biotech, United Kingdom

Tagged , , , , , , ,